Report and termination of the liquidity contract with Gilbert Dupont
The company Innate Pharma and the brokerage firm Gilbert Dupont have ended the liquidity contract signed on July 27, 2012. The termination is effective from May 13, 2016 after market.
As at May 13, 2016 after market, the following assets appeared on the liquidity account:
- 18,575 shares of Innate Pharma that will be kept in shares portfolio, and
- 372,807.10 euros in cash.
As a reminder, at December 31, 2015, the following assets appeared on the liquidity account:
- 22,128 shares of Innate Pharma, and
- 358,336.72 euros in cash.